Clonal Evolution in Patients with Relapsed Myelodysplastic Syndrome after Hematopoietic Stem-cell Transplantation

被引：0
|
作者：
Urbanova, Zuzana [1 ]
Vesela, Jitka [1 ]
Hruba, Monika [1 ]
Votavova, Hana [1 ]
Cechova, Hana [1 ]
Markova, Marketa St'astna [1 ]
Cermak, Jaroslav [1 ]
Belickova, Monika [1 ]
机构：
[1] Inst Hematol & Blood Transfus, Prague, Czech Republic
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P692
引用
收藏
页码：663 / 664
页数：2
相关论文
共 50 条
  • [1] Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndrome
    Cutler, Corey
    HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2010, : 325 - 329
  • [2] Somatic Mutations Predict Poor Outcome in Patients With Myelodysplastic Syndrome After Hematopoietic Stem-Cell Transplantation
    Bejar, Rafael
    Stevenson, Kristen E.
    Caughey, Bennett
    Lindsley, R. Coleman
    Mar, Brenton G.
    Stojanov, Petar
    Getz, Gad
    Steensma, David P.
    Ritz, Jerome
    Soiffer, Robert
    Antin, Joseph H.
    Alyea, Edwin
    Armand, Philippe
    Ho, Vincent
    Koreth, John
    Neuberg, Donna
    Cutler, Corey S.
    Ebert, Benjamin L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) : 2691 - +
  • [3] Epidemiology of Second Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed Myelodysplastic Syndrome
    Shimomura, Yoshimitsu
    Hara, Masahiko
    Tachibana, Takayoshi
    Ohashi, Kazuteru
    Ozawa, Yukiyasu
    Eto, Tetsuya
    Uchida, Naoyuki
    Mori, Takehiko
    Kanda, Junya
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Ishikawa, Takayuki
    Ishiyama, Ken
    BLOOD, 2018, 132
  • [4] Prognostic somatic mutations in patients with myelodysplastic syndrome treated with hematopoietic stem-cell transplantation
    Liu, Zixian
    Cao, Shanbo
    Lou, Feng
    Sun, Ying
    Wang, Chengcheng
    Han, Mingzhe
    Jiang, Erlie
    BONE MARROW TRANSPLANTATION, 2019, 54 : 513 - 513
  • [5] Hematopoietic stem cell transplantation in patients with myelodysplastic syndrome
    Deeg, HJ
    Frederick, FR
    LEUKEMIA RESEARCH, 2000, 24 (08) : 653 - 663
  • [6] Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation
    Lindsley, R. C.
    Saber, W.
    Mar, B. G.
    Redd, R.
    Wang, T.
    Haagenson, M. D.
    Grauman, P. V.
    Hu, Z. -H.
    Spellman, S. R.
    Lee, S. J.
    Verneris, M. R.
    Hsu, K.
    Fleischhauer, K.
    Cutler, C.
    Antin, J. H.
    Neuberg, D.
    Ebert, B. L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (06): : 536 - 547
  • [7] Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome
    Parmar, Simrit
    de Lima, Marcos
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (01) : S37 - S44
  • [8] Discordant Response of Systemic Mastocytosis Associated With Myelodysplastic Syndrome After Midostaurin and Allogeneic Hematopoietic Stem-cell Transplantation
    Haas, Marion
    Houot, Roch
    Llamas-Gutierrez, Francisco
    Boulland, Marie-Laure
    Roussel, Mikael
    Lamy, Thierry
    Fest, Thierry
    Pastoret, Cedric
    HEMASPHERE, 2020, 4 (06): : E478
  • [9] Selection of Patients With Myelodysplastic Syndrome for Allogeneic Hematopoietic Stem Cell Transplantation
    Mishra, Asmita
    Anasetti, Claudio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 : S49 - S52
  • [10] Results of donor lymphocyte infusions for relapsed myelodysplastic syndrome after hematopoietic cell transplantation
    Campregher, P. V.
    Gooley, T.
    Scott, B. L.
    Moravec, C.
    Sandmaier, B.
    Martin, P. J.
    Deeg, H. J.
    Warren, E. H.
    Flowers, M. E. D.
    BONE MARROW TRANSPLANTATION, 2007, 40 (10) : 965 - 971
12345